MARKETING ANALYSIS OF VACCINES USED FOR INFLUENZA IMMUNOPROPHYLAXIS IN THE REPUBLIC OF BASHKORTOSTAN-Reference-Cited by-同舟云学术

MARKETING ANALYSIS OF VACCINES USED FOR INFLUENZA IMMUNOPROPHYLAXIS IN THE REPUBLIC OF BASHKORTOSTAN

Published:2022-10-31 Issue: Volume: Page:91-95
ISSN:2686-6838
Container-title:"Medical & pharmaceutical journal "Pulse"
language:ru
Short-container-title:Mediko-farmacevtičeskij žurnal "Pulʹs"

Author:

L.M. Gabdulkhakova¹^ORCID,Zh.V. Mironenkova²^ORCID,S.Z. Umarov²^ORCID,L.M. Sharipova³,K.M. Akpaeva⁴^ORCID

Affiliation:

1. Bashkir State Medical University of the Ministry of Health of Russian Federation, Ufa, Russian Federation

2. Saint Petersburg State Chemical and Pharmaceutical University, Saint Petersburg, Russian Federation

3. Republican Skin and Venereological Dispensary, Ufa, Russian Federation

4. Non-profit joint-stock company «Astana Medical University», Nur-Sultan, Republic of Kazakhstan

Abstract

The study of cases of infectious diseases detected for the first time in the Republic of Bashkortostan (RB) revealed that in the group of infectious diseases, the nature of which is well studied, but the system of effective measures to combat them has not yet been developed, the greatest increase in morbidity in 2020 compared to 2015 was observed for influenza - by 341.16%. Therefore, the topic of marketing analysis on vaccines used in influenza immunoprophylaxis is relevant and timely. The analysis of the range of vaccines for the prevention of influenza was carried out by us according to the pharmaceutical market of the Republic of Bashkortostan, taking into account the information of the information and analytical system «State Register of Medicines» (GRLS) as of 08/23/2022 and presented by the 4th generation (generations). It was found that in the 2020/2021 epidemic season, relative to the 2015/2016 epidemic season, with a general decrease in the range of vaccines in the pharmaceutical market of the Republic of Bashkortostan, there was a 30.00% increase in the share of trivalent vaccines and 10.84% increase in the share of quadrivalent vaccines, the effectiveness of which increases the antigenic coincidence of influenza virus lines, the amount of costs prevented. Within the framework of the National Calendar of Preventive Vaccinations in the Republic of Bashkortostan, the transition to quadrivalent vaccines for immunoprophylaxis was not carried out, however, these vaccines were purchased by the population and organizations of Republic of Bashkortostan in pharmaceutical organizations for additional funds.

Publisher

Technomed Holdings LLC

Subject

General Earth and Planetary Sciences,General Environmental Science

Reference5 articles.

1. Order of the Ministry of Health of the Russian Federation No. 1122n dated 06.12.2021 "On approval of the national calendar of preventive vaccinations, the calendar of preventive vaccinations for epidemic indications and the procedure for preventive vaccinations".

2. Department of the Federal Service for Supervision of Consumer Rights Protection and Human Welfare in the Republic of Bashkortostan. [electronic resource]. – URL: http://02.rospotrebnadzor.ru (accessed: 08/23/2022).

3. Alpatova N. A., Avdeeva Zh. I., Lysikova S. L., Golovinskaya O. V., Gaiderova L. A., Bondarev V. P. General characteristics of adjuvants and the mechanism of their action (Part 2) // Biopreparations. Prevention, diagnosis, treatment. 2021. No. 1. [Electronic resource]. – URL: https://cyberleninka.ru/article/n/obschaya-harakteristika-adyuvantov-i-mehanizm-ih-deystviya-chast-2 (date of reference: 08/26/2022).

4. State Register of Medicines [Electronic resource]. – URL: http://grls.rosminzdrav.ru/grls.aspx \ (date of reference: 08/23/2022).

5. Harit S. M., Rudakova A.V., Uskov A. N., Konovalova L.N., Lobzin Yu. V., Prevented damage during vaccination against influenza with 3 and 4 valent vaccines. - Journal of Infectology. - 2017. - Volume 9(2). – pp. 17-22 [Electronic resource]. – URL: https://doi.org/10/22625/2072-6732-2017-9-2-17-22 (date of application: 08/23/2022).